arrow
O

Olivier Rascol

Université de Lille
H指数:110
被引数:5.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Radiological signature of levodopa responsiveness in Parkinson's disease: A data driven approach in a deep brain stimulation cohort

帕金森病中左旋多巴反应性的放射学特征:一项基于深度脑刺激队列的数据驱动方法

2026-09-010
PRE
Risk of Falls and Need of Walking Aid in Parkinson's Disease: Incidence and Impact of Comorbidities

帕金森病中跌倒风险与行走辅助需求:合并症的发病率和影响

2026-01-300
PRE
Early start of opicapone in Parkinson’s disease: evidence from a pooled analysis of phase 3 trials for sustained benefit in patients with recent onset of motor fluctuations

帕金森病中奥匹卡朋的早期开始:来自一项合并分析的证据,该分析基于3期试验,表明对于近期出现运动波动的患者具有持续获益。

2025-12-150
OAAI
Reply to: Letter to the Editor

回复:致编辑的信

2025-12-010
PRE
Effect on Dyskinesia of the Early Combination of Amantadine to Levodopa-Therapy in Parkinson's Disease: A Randomized, Placebo-Controlled Study (PREMANDYSK)

早期将金刚烷胺与左旋多巴疗法联合应用于帕金森病对运动障碍的影响:一项随机、安慰剂对照研究(PREMANDYSK)

2025-11-010
OAAI
Transforming Care Across Countries: Lessons from the Integrated Care Networks for Parkinson's Disease Study (iCARE-PD)

跨国护理转型:来自帕金森病综合护理网络研究(iCARE-PD)的经验

2025-11-010
OAAI
Advertising to Healthcare Professionals: Insights from Parkinson's Disease in the Movement Disorders Journal

向医疗专业人员发布广告:来自《运动障碍杂志》中帕金森病的见解

2025-10-300
OAAI
Stridor Is an Independent Risk Factor for Mortality and Disease Progression in Patients with Multiple System Atrophy

喉喘鸣是影响多系统萎缩患者死亡率和疾病进展的独立危险因素。

2025-10-010
OAAI
Validation of the French Translation of the Movement Disorder Society Non-Motor Symptoms Scale (MDS-NMS) in Parkinson's Disease

法国版运动障碍协会非运动症状量表(MDS-NMS)在帕金森病中的验证

2025-09-010
OAAI
Disease Progression in Multiple System Atrophy: The ASPIRE Multi-Modal Biomarker Study

多系统萎缩中的疾病进展:ASPIRE多模态生物标志物研究

2025-08-260
OAAI
Development and Feasibility of a Mixed Virtual and in-Presence Therapeutic Education Program for Early Multiple System Atrophy Patients

混合虚拟与现实治疗教育项目在早期多系统萎缩患者中的开发与可行性研究

2025-08-060
OA
Correction: Opicapone for the treatment of early wearing-off in levodopa-treated Parkinson’s disease: pooled analysis of patient level data from two randomized open-label studies

Correction: 奥匹卡朋治疗左旋多巴治疗的帕金森病早期“开关”现象:两项随机开放标签研究的患者层面数据合并分析

2025-08-010
OAAI
Deep Learning to Differentiate Parkinsonian Syndromes Using Multimodal Magnetic Resonance Imaging: A Proof-of-Concept Study

基于多模态磁共振成像的深度学习区分帕金森综合征:一项概念验证研究

2025-07-240
OAAI
Subcutaneous Apomorphine Infusion Initiation Is Associated with Impulse Control Disorder Attenuation in Advanced Parkinson's Disease Patients: Insights from the French NS-Park Cohort

皮下阿扑吗啡输注的启动与帕金森病晚期患者冲动控制障碍的缓解相关:来自法国NS-Park队列的见解

2025-07-170
OAAI
Parkinson's Disease, Speech and Neurosurgery

帕金森病,言语和神经外科

2025-04-290
OAAI
Subthalamic and nigral stimulation for freezing of gait in Parkinson's disease: Randomized pilot trial
2025-01-170
OA
Therapeutic modalities of deferiprone in Parkinson's disease: SKY and EMBARK studies
2024-12-270
OA